"Stage II colorectal cancer" trang 1 - tải miễn phí từ tailieunhanh
Using oral tegafur/uracil (UFT) plus leucovorin as adjuvant chemotherapy in stage II colorectal cancer: A propensity score matching study from Taiwan

Using oral tegafur/uracil (UFT) plus leucovorin as adjuvant chemotherapy in stage II colorectal cancer: A propensity score matching study from Taiwan
11    1    1
Extensively disturbance of regulatory T cells - Th17 cells balance in stage II pulmonary sarcoidosis

Extensively disturbance of regulatory T cells - Th17 cells balance in stage II pulmonary sarcoidosis
7    76    0
Postoperative XELOX therapy for patients with curatively resected high-risk stage II and stage III rectal cancer without preoperative chemoradiation: A prospective, multicenter, open-label, singlearm phase II study

Postoperative XELOX therapy for patients with curatively resected high-risk stage II and stage III rectal cancer without preoperative chemoradiation: A prospective, multicenter, open-label, singlearm phase II study
8    63    0
Programmed Death Ligand-1 expression in stage II colon cancer - experiences from a nationwide populationbased cohort

Programmed Death Ligand-1 expression in stage II colon cancer - experiences from a nationwide populationbased cohort
9    52    1
RKIP phosphorylation and STAT3 activation is inhibited by oxaliplatin and camptothecin and are associated with poor prognosis in stage II colon cancer patients

RKIP phosphorylation and STAT3 activation is inhibited by oxaliplatin and camptothecin and are associated with poor prognosis in stage II colon cancer patients
13    71    1
Prognostic significance of MUC2, CDX2 and SOX2 in stage II colorectal cancer patients

Prognostic significance of MUC2, CDX2 and SOX2 in stage II colorectal cancer patients
13    27    1
Preliminary results of treatment extranodal NK/T-Cell lymphoma, nasal type stage I-II at K hospital

Preliminary results of treatment extranodal NK/T-Cell lymphoma, nasal type stage I-II at K hospital
5    55    1
Risk factors for recurrence in elderly patients with stage II colorectal cancer: A multicenter retrospective study

Risk factors for recurrence in elderly patients with stage II colorectal cancer: A multicenter retrospective study
7    16    1
Risk factors for postoperative recurrence in patients with stage II colorectal cancer

Risk factors for postoperative recurrence in patients with stage II colorectal cancer
9    1    1
Size and number of lymph nodes were risk factors of recurrence in stage II colorectal cancer

Size and number of lymph nodes were risk factors of recurrence in stage II colorectal cancer
10    9    1
Effect of irrigation and nitrogen levels on nitrogen content, uptake and water productivity of clusterbean (Cyamopsis tetragonoloba) in IGNP stage-II

Effect of irrigation and nitrogen levels on nitrogen content, uptake and water productivity of clusterbean (Cyamopsis tetragonoloba) in IGNP stage-II
6    54    1
Treatment optimization of pelvic external beam radiation and/or vaginal brachytherapy for patients with stage I to II high-risk Endometrioid adenocarcinoma: A retrospective multi-institutional analysis

Treatment optimization of pelvic external beam radiation and/or vaginal brachytherapy for patients with stage I to II high-risk Endometrioid adenocarcinoma: A retrospective multi-institutional analysis
10    34    1
Impact of age on the use of adjuvant treatments in patients undergoing surgery for colorectal cancer: Patients with stage III colon or stage II/III rectal cancer

Impact of age on the use of adjuvant treatments in patients undergoing surgery for colorectal cancer: Patients with stage III colon or stage II/III rectal cancer
15    64    0
Adjuvant radiotherapy improves cause specific survival in stage II, not stage III mucinous carcinoma of the rectum

Adjuvant radiotherapy improves cause specific survival in stage II, not stage III mucinous carcinoma of the rectum
6    27    1
Randomized phase III clinical trial comparing the combination of capecitabine and oxaliplatin (CAPOX) with the combination of 5-fluorouracil, leucovorin and oxaliplatin (modified FOLFOX6) as adjuvant therapy in patients with operated high-risk stage II or stage III colorectal cancer

Randomized phase III clinical trial comparing the combination of capecitabine and oxaliplatin (CAPOX) with the combination of 5-fluorouracil, leucovorin and oxaliplatin (modified FOLFOX6) as adjuvant therapy in patients with operated high-risk stage II or stage III colorectal cancer
11    49    1
Predictors of recurrence free survival for patients with stage II and III colon cancer

Predictors of recurrence free survival for patients with stage II and III colon cancer
7    51    1
Cyclin-dependent kinase-specific activity predicts the prognosis of stage I and stage II non-small cell lung cancer

Cyclin-dependent kinase-specific activity predicts the prognosis of stage I and stage II non-small cell lung cancer
10    41    1
The 5-year overall survival of cervical cancer in stage IIIC-r was little different to stage I and II: A retrospective analysis from a single center

The 5-year overall survival of cervical cancer in stage IIIC-r was little different to stage I and II: A retrospective analysis from a single center
8    39    1
Single fraction ablative preoperative radiation treatment for early-stage breast cancer: The CRYSTAL study – a phase I/II clinical trial protocol

Single fraction ablative preoperative radiation treatment for early-stage breast cancer: The CRYSTAL study – a phase I/II clinical trial protocol
12    25    1
Effects of deficient mismatch repair on the prognosis of patients with stage II and stage III colon cancer during different postoperative periods

Effects of deficient mismatch repair on the prognosis of patients with stage II and stage III colon cancer during different postoperative periods
12    8    1